GAROFALO HEALTH CARE SPA (GHC.MI) Stock Fundamental Analysis

BIT:GHC • IT0005345233

5.51 EUR
+0.03 (+0.55%)
Last: Feb 17, 2026, 01:49 PM
Fundamental Rating

4

Taking everything into account, GHC scores 4 out of 10 in our fundamental rating. GHC was compared to 29 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of GHC get a neutral evaluation. Nothing too spectacular is happening here. GHC is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • GHC had positive earnings in the past year.
  • In the past year GHC had a positive cash flow from operations.
  • Each year in the past 5 years GHC has been profitable.
  • GHC had a positive operating cash flow in each of the past 5 years.
GHC.MI Yearly Net Income VS EBIT VS OCF VS FCFGHC.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

1.2 Ratios

  • With a decent Return On Assets value of 3.66%, GHC is doing good in the industry, outperforming 68.97% of the companies in the same industry.
  • GHC's Return On Equity of 9.57% is in line compared to the rest of the industry. GHC outperforms 58.62% of its industry peers.
  • With a decent Return On Invested Capital value of 6.52%, GHC is doing good in the industry, outperforming 75.86% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for GHC is in line with the industry average of 6.14%.
  • The last Return On Invested Capital (6.52%) for GHC is above the 3 year average (4.41%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.66%
ROE 9.57%
ROIC 6.52%
ROA(3y)2.83%
ROA(5y)2.81%
ROE(3y)7.12%
ROE(5y)6.88%
ROIC(3y)4.41%
ROIC(5y)3.91%
GHC.MI Yearly ROA, ROE, ROICGHC.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • With a decent Profit Margin value of 4.62%, GHC is doing good in the industry, outperforming 75.86% of the companies in the same industry.
  • In the last couple of years the Profit Margin of GHC has declined.
  • Looking at the Operating Margin, with a value of 9.37%, GHC is in the better half of the industry, outperforming 79.31% of the companies in the same industry.
  • GHC's Operating Margin has declined in the last couple of years.
  • With a decent Gross Margin value of 44.90%, GHC is doing good in the industry, outperforming 68.97% of the companies in the same industry.
  • GHC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.37%
PM (TTM) 4.62%
GM 44.9%
OM growth 3Y-0.19%
OM growth 5Y-3.37%
PM growth 3Y-11.52%
PM growth 5Y-7.03%
GM growth 3Y0.36%
GM growth 5Y-1.06%
GHC.MI Yearly Profit, Operating, Gross MarginsGHC.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

4

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so GHC is destroying value.
  • Compared to 1 year ago, GHC has about the same amount of shares outstanding.
  • GHC has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, GHC has an improved debt to assets ratio.
GHC.MI Yearly Shares OutstandingGHC.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
GHC.MI Yearly Total Debt VS Total AssetsGHC.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • GHC has an Altman-Z score of 1.96. This is not the best score and indicates that GHC is in the grey zone with still only limited risk for bankruptcy at the moment.
  • GHC has a Altman-Z score (1.96) which is in line with its industry peers.
  • The Debt to FCF ratio of GHC is 70.49, which is on the high side as it means it would take GHC, 70.49 years of fcf income to pay off all of its debts.
  • GHC has a worse Debt to FCF ratio (70.49) than 72.41% of its industry peers.
  • GHC has a Debt/Equity ratio of 0.67. This is a neutral value indicating GHC is somewhat dependend on debt financing.
  • The Debt to Equity ratio of GHC (0.67) is better than 79.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF 70.49
Altman-Z 1.96
ROIC/WACC0.99
WACC6.58%
GHC.MI Yearly LT Debt VS Equity VS FCFGHC.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 1.16 indicates that GHC should not have too much problems paying its short term obligations.
  • GHC has a Current ratio of 1.16. This is in the better half of the industry: GHC outperforms 62.07% of its industry peers.
  • GHC has a Quick Ratio of 1.12. This is a normal value and indicates that GHC is financially healthy and should not expect problems in meeting its short term obligations.
  • GHC's Quick ratio of 1.12 is fine compared to the rest of the industry. GHC outperforms 75.86% of its industry peers.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.12
GHC.MI Yearly Current Assets VS Current LiabilitesGHC.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

4

3. Growth

3.1 Past

  • The earnings per share for GHC have decreased strongly by -12.11% in the last year.
  • The Earnings Per Share has been growing by 8.81% on average over the past years. This is quite good.
  • The Revenue has grown by 10.44% in the past year. This is quite good.
  • GHC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 18.92% yearly.
EPS 1Y (TTM)-12.11%
EPS 3Y5.52%
EPS 5Y8.81%
EPS Q2Q%2.71%
Revenue 1Y (TTM)10.44%
Revenue growth 3Y18.48%
Revenue growth 5Y18.92%
Sales Q2Q%3.08%

3.2 Future

  • The Earnings Per Share is expected to grow by 6.47% on average over the next years.
  • The Revenue is expected to grow by 1.51% on average over the next years.
EPS Next Y3.45%
EPS Next 2Y5.05%
EPS Next 3Y6.47%
EPS Next 5YN/A
Revenue Next Year3.78%
Revenue Next 2Y4.6%
Revenue Next 3Y3.74%
Revenue Next 5Y1.51%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
GHC.MI Yearly Revenue VS EstimatesGHC.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M 500M
GHC.MI Yearly EPS VS EstimatesGHC.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3

3

4. Valuation

4.1 Price/Earnings Ratio

  • GHC is valuated correctly with a Price/Earnings ratio of 15.31.
  • GHC's Price/Earnings ratio is a bit cheaper when compared to the industry. GHC is cheaper than 68.97% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.16. GHC is valued slightly cheaper when compared to this.
  • With a Price/Forward Earnings ratio of 17.05, GHC is valued on the expensive side.
  • Based on the Price/Forward Earnings ratio, GHC is valued a bit more expensive than the industry average as 62.07% of the companies are valued more cheaply.
  • When comparing the Price/Forward Earnings ratio of GHC to the average of the S&P500 Index (28.10), we can say GHC is valued slightly cheaper.
Industry RankSector Rank
PE 15.31
Fwd PE 17.05
GHC.MI Price Earnings VS Forward Price EarningsGHC.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, GHC is valued cheaply inside the industry as 82.76% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of GHC indicates a slightly more expensive valuation: GHC is more expensive than 72.41% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 153.02
EV/EBITDA 7.51
GHC.MI Per share dataGHC.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates GHC does not grow enough to justify the current Price/Earnings ratio.
  • The decent profitability rating of GHC may justify a higher PE ratio.
PEG (NY)4.44
PEG (5Y)1.74
EPS Next 2Y5.05%
EPS Next 3Y6.47%

2

5. Dividend

5.1 Amount

  • GHC has a Yearly Dividend Yield of 1.56%.
  • Compared to an average industry Dividend Yield of 1.79, GHC has a dividend in line with its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.82, GHC has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.56%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y5.05%
EPS Next 3Y6.47%
GHC.MI Yearly Income VS Free CF VS DividendGHC.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

GAROFALO HEALTH CARE SPA

BIT:GHC (2/17/2026, 1:49:22 PM)

5.51

+0.03 (+0.55%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-14
Earnings (Next)N/A
Inst Owners11.85%
Inst Owner ChangeN/A
Ins Owners63%
Ins Owner ChangeN/A
Market Cap497.00M
Revenue(TTM)690.85M
Net Income(TTM)31.91M
Analysts84
Price Target6.73 (22.14%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.56%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 15.31
Fwd PE 17.05
P/S 0.72
P/FCF 153.02
P/OCF 17.79
P/B 1.49
P/tB N/A
EV/EBITDA 7.51
EPS(TTM)0.36
EY6.53%
EPS(NY)0.32
Fwd EY5.87%
FCF(TTM)0.04
FCFY0.65%
OCF(TTM)0.31
OCFY5.62%
SpS7.66
BVpS3.7
TBVpS-0.44
PEG (NY)4.44
PEG (5Y)1.74
Graham Number5.47
Profitability
Industry RankSector Rank
ROA 3.66%
ROE 9.57%
ROCE 9.13%
ROIC 6.52%
ROICexc 6.77%
ROICexgc 14.86%
OM 9.37%
PM (TTM) 4.62%
GM 44.9%
FCFM 0.47%
ROA(3y)2.83%
ROA(5y)2.81%
ROE(3y)7.12%
ROE(5y)6.88%
ROIC(3y)4.41%
ROIC(5y)3.91%
ROICexc(3y)4.63%
ROICexc(5y)4.13%
ROICexgc(3y)10.78%
ROICexgc(5y)9.37%
ROCE(3y)6.5%
ROCE(5y)5.8%
ROICexgc growth 3Y7.97%
ROICexgc growth 5Y2.8%
ROICexc growth 3Y6.71%
ROICexc growth 5Y0.74%
OM growth 3Y-0.19%
OM growth 5Y-3.37%
PM growth 3Y-11.52%
PM growth 5Y-7.03%
GM growth 3Y0.36%
GM growth 5Y-1.06%
F-Score5
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF 70.49
Debt/EBITDA 2.47
Cap/Depr 94.13%
Cap/Sales 3.57%
Interest Coverage 6.62
Cash Conversion 30.7%
Profit Quality 10.18%
Current Ratio 1.16
Quick Ratio 1.12
Altman-Z 1.96
F-Score5
WACC6.58%
ROIC/WACC0.99
Cap/Depr(3y)82.25%
Cap/Depr(5y)102.09%
Cap/Sales(3y)4.73%
Cap/Sales(5y)5.79%
Profit Quality(3y)118.21%
Profit Quality(5y)101.66%
High Growth Momentum
Growth
EPS 1Y (TTM)-12.11%
EPS 3Y5.52%
EPS 5Y8.81%
EPS Q2Q%2.71%
EPS Next Y3.45%
EPS Next 2Y5.05%
EPS Next 3Y6.47%
EPS Next 5YN/A
Revenue 1Y (TTM)10.44%
Revenue growth 3Y18.48%
Revenue growth 5Y18.92%
Sales Q2Q%3.08%
Revenue Next Year3.78%
Revenue Next 2Y4.6%
Revenue Next 3Y3.74%
Revenue Next 5Y1.51%
EBIT growth 1Y-8.88%
EBIT growth 3Y18.26%
EBIT growth 5Y14.91%
EBIT Next Year68.09%
EBIT Next 3Y22.98%
EBIT Next 5Y16.09%
FCF growth 1Y-88.34%
FCF growth 3Y4.79%
FCF growth 5Y6.69%
OCF growth 1Y-35.2%
OCF growth 3Y-1.23%
OCF growth 5Y13.09%

GAROFALO HEALTH CARE SPA / GHC.MI FAQ

What is the ChartMill fundamental rating of GAROFALO HEALTH CARE SPA (GHC.MI) stock?

ChartMill assigns a fundamental rating of 4 / 10 to GHC.MI.


What is the valuation status for GHC stock?

ChartMill assigns a valuation rating of 3 / 10 to GAROFALO HEALTH CARE SPA (GHC.MI). This can be considered as Overvalued.


How profitable is GAROFALO HEALTH CARE SPA (GHC.MI) stock?

GAROFALO HEALTH CARE SPA (GHC.MI) has a profitability rating of 6 / 10.


What is the financial health of GAROFALO HEALTH CARE SPA (GHC.MI) stock?

The financial health rating of GAROFALO HEALTH CARE SPA (GHC.MI) is 4 / 10.


What is the expected EPS growth for GAROFALO HEALTH CARE SPA (GHC.MI) stock?

The Earnings per Share (EPS) of GAROFALO HEALTH CARE SPA (GHC.MI) is expected to grow by 3.45% in the next year.